NOV 14, 2018 09:00 AM PST

Accelerating Cancer Research and Clinical Innovations Using OncoLand

SPONSORED BY: QIAGEN
C.E. CREDITS: P.A.C.E. CE | Florida CE
Speakers
  • Sr. Scientist, Bioinformatics, QIAGEN
    Biography
      Dr. Zhou is a professional scientist with more than 10 years of experience in oncology, cancer genetics, and preclinical drug discovery. She previously works as research associate in the Lineberger Cancer Center of University of Carolina at Chapel Hill, where her interests are centered around molecular mechanisms of breast cancer and prostate cancer using animal models. Her experiences in industry includes target discovery and validation, cell-based assay development, and small molecules screening. Currently, Bing is managing Oncoland curation team within OmicSoft, a QIAGEN company. So far, OncoLand curation team has curated thousands of projects from cancer genomics consortia as well as public data repositories. Her knowledge on cancer biology and clinical ontologies has supported the establishment of internal curation standards.

    Abstract:

    With significant decrease in the cost of sequencing in numerous commercial as well as cancer center–driven initiatives, genomic profiling is increasingly becoming routine across multiple cancer types. There is a large amount of diverse omic-data that has been generated, which are either publicly accessible through numerous repositories or managed through controlled data archives. However, the sheer volume and diversity of the data presents a significant challenge in data management and analysis. 

    OncoLand is an integrated oncology genomics repository and visualization platform. Feature tremendous numbers of consortia data and tens of thousands of processed and carefully curated cancer genomics datasets from public domains. The OncoLand tool enables investigators to easily query and navigate a gene or sets of genes of interest in multiple tumors across data from different platforms, including DNA mutation, gene expression and fusion, copy number, protein, and methylation. The built-in Omicsoft Genome Browser (OGB) allows a detailed view of coverage, gene fusions and alternatively spliced isoforms. OncoLand contains a variety of modules for integrative analysis, comparisons, and clinical associations explorations. OncoLand has become an invaluable platform to accelerate successful cancer research and clinical innovations.


    Show Resources
    You May Also Like
    SEP 05, 2019 04:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 04:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    OCT 02, 2019 11:00 AM PDT
    OCT 02, 2019 11:00 AM PDT
    DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
    AUG 27, 2019 09:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 09:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    NOV 18, 2019 07:00 AM PST
    C.E. CREDITS
    NOV 18, 2019 07:00 AM PST
    DATE: November 18, 2019TIME: 7:00am PST, 11:00am EST, 4:00pm CEWT How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop th...
    JUL 30, 2019 10:00 AM PDT
    C.E. CREDITS
    JUL 30, 2019 10:00 AM PDT
    DATE: July 30, 2019TIME: 10:00am PT/ 1:00pm ET The importance of building a validation structure within your lab cannot be overstated. Once in place, the ability to identify high...
    JUN 26, 2019 09:00 AM PDT
    C.E. CREDITS
    JUN 26, 2019 09:00 AM PDT
    DATE: June 26, 2019TIME: 9:00am PDT, 12:00pm EDT An excessive number of software solutions are available to help manage your clinical, biobank, or biorepository sample inform...
    Loading Comments...
    Show Resources